Back to User profile » Dr Jamal Tarazi
Papers published by Dr Jamal Tarazi:
Clinical Trial Report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma
Karakiewicz PI, Nott L, Joshi A, Kannourakis G, Tarazi J, Alam M
OncoTargets and Therapy 2016, 9:2855-2863
Published Date: 12 May 2016
Original Research
![Noteworthy comment: The paper is important because it is the first phase III trial after the registrative trial investigating the role of axitinib in Asian population.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study
Qin S, Bi F, Jin J, Cheng Y, Guo J, Ren X, Huang Y, Tarazi J, Tang J, Chen C, Kim S, Ye D
OncoTargets and Therapy 2015, 8:1363-1373
Published Date: 8 June 2015